Treatment of schizophrenia and comorbid substance use disorder.
about
Atypicality of atypical antipsychotics.Substance abuse and schizophrenia: pharmacotherapeutic interventionAssociation study identifying a new susceptibility gene (AUTS2) for schizophreniaAlcohol use disorders contribute to hippocampal and subcortical shape differences in schizophrenia.The treatment of schizophrenia: from premorbid manifestations to the first episode of psychosis.Treatment of substance abusing patients with comorbid psychiatric disorders.Assessing the efficacy of medical treatments for alcohol use disorders.Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision.Characterizing the longitudinal patterns of substance use among individuals diagnosed with serious mental illness after psychiatric hospitalization.The Effects of Acupuncture Treatment on Sleep Quality and on Emotional Measures among Individuals Living with Schizophrenia: A Pilot Study.Cannabis-related working memory deficits and associated subcortical morphological differences in healthy individuals and schizophrenia subjects.Psychiatric co-morbidity and substance use disorders: treatment in parallel systems or in one integrated system?Pharmacological treatment of schizophrenia with comorbid substance use disorder.Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions.Axis IV psychosocial problems among patients with psychotic or mood disorders with a cannabis use disorder comorbidity.Pharmacological treatment of alcohol abuse/dependence with psychiatric comorbidity.Is it time to consider comorbid substance abuse as a new indication for antipsychotic drug development?Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy.An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses.Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for Psychopharmacology.Relationship between anxiety and addiction to a depressant drug.The Risk Factors of the Alcohol Use Disorders-Through Review of Its Comorbidities.
P2860
Q24535908-40053E95-6C76-492E-8F6E-508D00A9644FQ24621711-B54ACA8C-D683-4B7F-A94A-5AD1775C0968Q34684940-6AE03EA3-3E75-487C-828D-62B2B3376441Q35175759-C8D4B1ED-132F-4902-B9AC-C3E93588A622Q35236574-8B443B99-03C0-4229-8A0E-B9517BB84B06Q35387756-026A9F42-9A57-43F3-9A83-ADC31A2A6F21Q35906903-36A2D948-4892-40F8-8A20-C8A4F48E9666Q36231851-28EFA093-6FC3-4DB7-9EEE-A3CEFEC79A37Q36920503-A9642EEB-CB7B-4F33-BB27-63F35230F968Q37180681-CEEF41BD-15D7-4CCE-9EEB-25C3ABD2BEA4Q37598266-BA152B77-4B6C-45DC-B7E9-E2AC20F443C5Q38016975-F30E1CB3-A10F-4111-ACDA-78D7A432CDCBQ38658672-1CFD7084-BF54-4510-9B17-6CC88C5BB715Q42251217-17EAD65D-7E2E-4330-8A75-67E762AACC8AQ43487337-E05C69BF-C704-4ADC-99FA-E1B51AE46F86Q44867680-09D337D2-D22C-4A05-A43E-BB336F5BCC49Q45929001-8847596A-3571-4628-9E9B-25CD8E4CC8A3Q46726987-08F50B7E-BF76-440B-B47A-94EF932C8ED5Q48908840-868FBE2E-419C-4535-A446-0DD6831CF4B3Q51937580-7A266892-0F71-4409-8F8F-052CDC86ABA8Q52294657-29D5EC61-A9D3-44D3-88CE-F514E2F81F98Q55262466-748D0913-D00D-4B9F-BA61-CF1437CD7710
P2860
Treatment of schizophrenia and comorbid substance use disorder.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Treatment of schizophrenia and comorbid substance use disorder.
@ast
Treatment of schizophrenia and comorbid substance use disorder.
@en
type
label
Treatment of schizophrenia and comorbid substance use disorder.
@ast
Treatment of schizophrenia and comorbid substance use disorder.
@en
prefLabel
Treatment of schizophrenia and comorbid substance use disorder.
@ast
Treatment of schizophrenia and comorbid substance use disorder.
@en
P2093
P356
P1476
Treatment of schizophrenia and comorbid substance use disorder.
@en
P2093
Alan I Green
Kimberly Rawlins
Mark J Brenner
Melinda S Salomon
P304
P356
10.2174/1568007024606230
P577
2002-04-01T00:00:00Z